218 related articles for article (PubMed ID: 28389356)
21. Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein.
Huang H; Lai S; Wan Q; Qi W; Liu J
Can J Physiol Pharmacol; 2016 May; 94(5):542-53. PubMed ID: 27070866
[TBL] [Abstract][Full Text] [Related]
22. Tanshinone IIA reduces apoptosis induced by hydrogen peroxide in the human endothelium-derived EA.hy926 cells.
Jia LQ; Yang GL; Ren L; Chen WN; Feng JY; Cao Y; Zhang L; Li XT; Lei P
J Ethnopharmacol; 2012 Aug; 143(1):100-8. PubMed ID: 22750433
[TBL] [Abstract][Full Text] [Related]
23. Janus kinase/signal transducer and activator of transcription inhibitors enhance the protective effect mediated by tanshinone IIA from hypoxic/ischemic injury in cardiac myocytes.
Zhang MQ; Tu JF; Chen H; Shen Y; Pang LX; Yang XH; Sun RH; Zheng YL
Mol Med Rep; 2015 Apr; 11(4):3115-21. PubMed ID: 25502794
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis.
Gao J; Yang G; Pi R; Li R; Wang P; Zhang H; Le K; Chen S; Liu P
Transl Res; 2008 Feb; 151(2):79-87. PubMed ID: 18201675
[TBL] [Abstract][Full Text] [Related]
25. Jujuboside A attenuates norepinephrine-induced apoptosis of H9c2 cardiomyocytes by modulating MAPK and AKT signaling pathways.
Wan CR; Han DD; Xu JQ; Yin P; Xu XL; Mei C; Liu FH; Xia ZF
Mol Med Rep; 2018 Jan; 17(1):1132-1140. PubMed ID: 29115535
[TBL] [Abstract][Full Text] [Related]
26. Astragaloside IV regulates expression of ATP-sensitive potassium channel subunits after ischemia-reperfusion in rat ventricular cardiomyocytes.
Han XH; Liu P; Zhang YY; Zhang N; Chen FR; Cai JF
J Tradit Chin Med; 2011 Dec; 31(4):321-6. PubMed ID: 22462239
[TBL] [Abstract][Full Text] [Related]
27. Astragaloside IV suppresses inflammatory mediator production in synoviocytes and collagen‑induced arthritic rats.
Xu H; Wang CY; Zhang HN; Lv CY; Wang YZ
Mol Med Rep; 2016 Apr; 13(4):3289-96. PubMed ID: 26936538
[TBL] [Abstract][Full Text] [Related]
28. Effect of Combined Use of Astragaloside IV (AsIV) and Atorvastatin (AV) on Expression of PPAR-γ and Inflammation-Associated Cytokines in Atherosclerosis Rats.
Sun B; Rui R; Pan H; Zhang L; Wang X
Med Sci Monit; 2018 Sep; 24():6229-6236. PubMed ID: 30190450
[TBL] [Abstract][Full Text] [Related]
29. Anti-apoptotic effect of heat shock protein 90 on hypoxia-mediated cardiomyocyte damage is mediated via the phosphatidylinositol 3-kinase/AKT pathway.
Wang W; Peng Y; Wang Y; Zhao X; Yuan Z
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):899-903. PubMed ID: 19298537
[TBL] [Abstract][Full Text] [Related]
30. Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation.
Weng YS; Wang HF; Pai PY; Jong GP; Lai CH; Chung LC; Hsieh DJ; HsuanDay C; Kuo WW; Huang CY
Am J Chin Med; 2015; 43(8):1567-91. PubMed ID: 26621443
[TBL] [Abstract][Full Text] [Related]
31. Astragaloside IV improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca-ATPase.
Xu XL; Chen XJ; Ji H; Li P; Bian YY; Yang D; Xu JD; Bian ZP; Zhang JN
Pharmacology; 2008; 81(4):325-32. PubMed ID: 18349554
[TBL] [Abstract][Full Text] [Related]
32. Aqueous extract of Cortex Dictamni protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis by PI3K/Akt signaling pathway.
Li L; Zhou Y; Li Y; Wang L; Sun L; Zhou L; Arai H; Qi Y; Xu Y
Biomed Pharmacother; 2017 May; 89():233-244. PubMed ID: 28231545
[TBL] [Abstract][Full Text] [Related]
33. Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways.
Guo J; Le Y; Yuan A; Liu J; Chen H; Qiu J; Wang C; Dou X; Yuan X; Lu D
J Ethnopharmacol; 2024 Jun; 328():118080. PubMed ID: 38521426
[TBL] [Abstract][Full Text] [Related]
34. Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice.
Li H; Wang P; Huang F; Jin J; Wu H; Zhang B; Wang Z; Shi H; Wu X
Toxicol Appl Pharmacol; 2018 Feb; 340():58-66. PubMed ID: 29294303
[TBL] [Abstract][Full Text] [Related]
35. Implication of IGF1R signaling in the protective effect of Astragaloside IV on ischemia and reperfusion-induced cardiac microvascular endothelial hyperpermeability.
He K; Yan L; Lin SQ; Liu YY; Hu BH; Chang X; Zhao XR; He SY; Wei XH; Fan JY; Pan CS; Han JY
Phytomedicine; 2022 Jun; 100():154045. PubMed ID: 35338991
[TBL] [Abstract][Full Text] [Related]
36. Astragaloside IV attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels.
Hu JY; Han J; Chu ZG; Song HP; Zhang DX; Zhang Q; Huang YS
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):351-7. PubMed ID: 18986331
[TBL] [Abstract][Full Text] [Related]
37. Triterpenoid saponins from Ilex cornuta protect H9c2 cardiomyocytes against H2O2-induced apoptosis by modulating Ezh2 phosphorylation.
Yu D; Zhu Z; Wang M; Ding X; Gui H; Ma J; Yan Y; Li G; Xu Q; Wang W; Mao C
J Ethnopharmacol; 2021 Apr; 269():113691. PubMed ID: 33321190
[TBL] [Abstract][Full Text] [Related]
38. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
[TBL] [Abstract][Full Text] [Related]
39. Astragaloside IV alleviates hypoxia/reoxygenation-induced neonatal rat cardiomyocyte injury via the protein kinase a pathway.
Zhang DW; Bian ZP; Xu JD; Wu HF; Gu CR; Zhou B; Chen XJ; Yang D
Pharmacology; 2012; 90(1-2):95-101. PubMed ID: 22797566
[TBL] [Abstract][Full Text] [Related]
40. Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1α accumulation via phosphatidylinositol 3-kinase/Akt pathway.
Zhang L; Liu Q; Lu L; Zhao X; Gao X; Wang Y
J Pharmacol Exp Ther; 2011 Aug; 338(2):485-91. PubMed ID: 21576377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
